$307.42
1.34% today
NYSE, Aug 22, 10:13 pm CET
ISIN
US91324P1021
Symbol
UNH

UnitedHealth Target price 2025 - Analyst rating & recommendation

UnitedHealth Classifications & Recommendation:

Buy
69%
Hold
19%
Sell
13%

UnitedHealth Price Target

Target Price $327.42
Price $307.42
Potential 6.51%
Number of Estimates 27
27 Analysts have issued a price target UnitedHealth 2026 . The average UnitedHealth target price is $327.42. This is 6.51% higher than the current stock price. The highest price target is $710.85 131.23% , the lowest is $199.98 34.95% .
A rating was issued by 32 analysts: 22 Analysts recommend UnitedHealth to buy, 6 to hold and 4 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the UnitedHealth stock has an average upside potential 2026 of 6.51% . Most analysts recommend the UnitedHealth stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2032


Dec '24 2025
Estimates
Revenue Billion $ 400.28 453.65
7.71% 13.33%
EBITDA Margin 9.09% 5.84%
7.02% 35.75%
Net Margin 3.60% 4.46%
40.25% 23.93%

26 Analysts have issued a sales forecast UnitedHealth 2025 . The average UnitedHealth sales estimate is $454b . This is 7.29% higher than the revenue of the last 12 months(TTM). The highest sales forecast is $480b 13.48% , the lowest is $431b 1.84% .

This results in the following potential growth metrics:

Revenue Estimates

2024 $400b 7.71%
2025 $454b 13.33%
2026 $482b 6.23%
2027 $515b 6.76%
2028 $551b 7.00%
2029 $596b 8.21%
2030 $597b 0.22%
2031 $629b 5.29%
2032 $662b 5.28%

24 Analysts have issued an UnitedHealth EBITDA forecast 2025. The average UnitedHealth EBITDA estimate is $26.5b . This is 24.23% lower than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is $29.4b 16.05% , the lowest is $25.2b 28.00% .

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $36.4b 0.15%
2025 $26.5b 27.16%
2026 $29.3b 10.47%
2027 $32.8b 11.92%
2028 $49.7b 51.54%
2029 $54.9b 10.54%
2030 $59.6b 8.54%
2031 $63.4b 6.44%
2032 $67.5b 6.46%

EBITDA Margin

2024 9.09% 7.02%
2025 5.84% 35.75%
2026 6.08% 4.11%
2027 6.37% 4.77%
2028 9.02% 41.60%
2029 9.21% 2.11%
2030 9.98% 8.36%
2031 10.09% 1.10%
2032 10.20% 1.09%

30 UnitedHealth Analysts have issued a net profit forecast 2025. The average UnitedHealth net profit estimate is $20.2b . This is 4.94% lower than the net profit for the last 12 months(TTM). The highest net profit forecast is $25.2b 18.26% , the lowest is $16.0b 24.86% .

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $14.4b 35.64%
2025 $20.2b 40.53%
2026 $23.5b 15.86%
2027 $26.8b 14.34%
2028 $33.2b 23.74%
2029 $37.9b 14.07%
2030 $42.0b 10.91%
2031 $47.3b 12.70%
2032 $53.3b 12.55%

Net Margin

2024 3.60% 40.25%
2025 4.46% 23.93%
2026 4.87% 9.19%
2027 5.21% 6.98%
2028 6.03% 15.74%
2029 6.36% 5.47%
2030 7.03% 10.53%
2031 7.53% 7.11%
2032 8.05% 6.91%

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2032


Dec '24 2025
Estimates
Earnings Per Share $ 15.51 22.32
35.00% 43.91%
P/E 13.59
EV/Sales 0.71

30 Analysts have issued a UnitedHealth forecast for earnings per share. The average UnitedHealth EPS is $22.32 . This is 4.62% lower than earnings per share in the financial year 2024. The highest EPS forecast is $27.76 18.63% , the lowest is $17.64 24.62% .

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $15.51 35.00%
2025 $22.32 43.91%
2026 $25.86 15.86%
2027 $29.56 14.31%
2028 $36.58 23.75%
2029 $41.73 14.08%
2030 $46.29 10.93%
2031 $52.17 12.70%
2032 $58.71 12.54%

P/E ratio

Current 12.96 65.91%
2025 13.59 4.83%
2026 11.73 13.69%
2027 10.26 12.53%
2028 8.29 19.20%
2029 7.27 12.30%
2030 6.55 9.90%
2031 5.82 11.15%
2032 5.17 11.17%

Based on analysts' sales estimates for 2025, the UnitedHealth stock is valued at an EV/Sales of 0.71 and an P/S ratio of 0.61 .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.76 51.90%
2025 0.71 6.63%
2026 0.67 5.86%
2027 0.63 6.33%
2028 0.58 6.55%
2029 0.54 7.58%
2030 0.54 0.22%
2031 0.51 5.03%
2032 0.49 5.02%

P/S ratio

Current 0.65 53.05%
2025 0.61 6.80%
2026 0.57 5.86%
2027 0.53 6.33%
2028 0.50 6.55%
2029 0.46 7.58%
2030 0.46 0.22%
2031 0.44 5.04%
2032 0.42 5.01%

Current UnitedHealth Upgrades & Downgrades

Analyst Rating Action Date
B of A Securities
Neutral
Neutral
Unchanged Aug 18 2025
JP Morgan
Overweight
Overweight
Unchanged Aug 06 2025
Wells Fargo
Overweight
Overweight
Unchanged Aug 04 2025
Baird
Neutral
Underperform
Downgrade Jul 31 2025
Keybanc
Overweight
Overweight
Unchanged Jul 30 2025
B of A Securities
Neutral
Neutral
Unchanged Jul 30 2025
Oppenheimer
Outperform
Outperform
Unchanged Jul 30 2025
Analyst Rating Date
Unchanged
B of A Securities:
Neutral
Neutral
Aug 18 2025
Unchanged
JP Morgan:
Overweight
Overweight
Aug 06 2025
Unchanged
Wells Fargo:
Overweight
Overweight
Aug 04 2025
Downgrade
Baird:
Neutral
Underperform
Jul 31 2025
Unchanged
Keybanc:
Overweight
Overweight
Jul 30 2025
Unchanged
B of A Securities:
Neutral
Neutral
Jul 30 2025
Unchanged
Oppenheimer:
Outperform
Outperform
Jul 30 2025

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today